RNA‐editing of the 5‐HT2C receptor alters agonist‐receptor‐effector coupling specificity
Open Access
- 1 September 2001
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 134 (2) , 386-392
- https://doi.org/10.1038/sj.bjp.0704255
Abstract
The serotonin2C (5‐HT2C) receptor couples to both phospholipase C (PLC)‐inositol phosphate (IP) and phospholipase A2 (PLA2)‐arachidonic acid (AA) signalling cascades. Agonists can differentially activate these effectors (i.e. agonist‐directed trafficking of receptor stimulus) perhaps due to agonist‐specific receptor conformations which differentially couple to/activate transducer molecules (e.g. G proteins). Since editing of RNA transcripts of the human 5‐HT2C receptor leads to substitution of amino acids at positions 156, 158 and 160 of the putative second intracellular loop, a region important for G protein coupling, we examined the capacity of agonists to activate both the PLC‐IP and PLA2‐AA pathways in CHO cells stably expressing two major, fully RNA‐edited isoforms (5‐HT2C‐VSV, 5‐HT2C‐VGV) of the h5‐HT2C receptor. 5‐HT increased AA release and IP accumulation in both 5‐HT2C‐VSV and 5‐HT2C‐VGV expressing cells. As expected, the potency of 5‐HT for both RNA‐edited isoforms for both responses was 10 fold lower relative to that of the non‐edited receptor (5‐HT2C‐INI) when receptors were expressed at similar levels. Consistent with our previous report, the efficacy order of two 5‐HT receptor agonists (TFMPP and bufotenin) was reversed for AA release and IP accumulation at the non‐edited receptor thus demonstrating agonist trafficking of receptor stimulus. However, with the RNA‐edited receptor isoforms there was no difference in the relative efficacies of TFMPP or bufotenin for AA release and IP accumulation suggesting that the capacity for 5‐HT2C agonists to traffic receptor stimulus is lost as a result of RNA editing. These results suggest an important role for the second intracellular loop in transmitting agonist‐specific information to signalling molecules. British Journal of Pharmacology (2001) 134, 386–392; doi:10.1038/sj.bjp.0704255Keywords
This publication has 29 references indexed in Scilit:
- Agonist-Directed Signaling of Serotonin 5-HT2C Receptors Differences Between Serotonin and Lysergic Acid Diethylamide (LSD)Neuropsychopharmacology, 1999
- Messenger RNA Editing of the Human Serotonin 5-HT2C ReceptorNeuropsychopharmacology, 1999
- Messenger RNA Editing of the Human Serotonin 5-HT2C ReceptorNeuropsychopharmacology, 1999
- Differential Involvement of Gα12 and Gα13 in Receptor-mediated Stress Fiber FormationJournal of Biological Chemistry, 1999
- Regulation of serotonin-2C receptor G-protein coupling by RNA editingNature, 1997
- RNA EditingAnnual Review of Neuroscience, 1996
- Agonist-receptor efficacy II: agonist trafficking of receptor signalsTrends in Pharmacological Sciences, 1995
- Serotonin 5‐HT2C Receptor Stimulates Cyclic GMP Formation in Choroid PlexusJournal of Neurochemistry, 1995
- Differential signal transduction by five splice variants of the PACAP receptorNature, 1993
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973